Zurini M, Krebs J, Penniston J T, Carafoli E
J Biol Chem. 1984 Jan 10;259(1):618-27.
The purified Ca2+-pumping ATPase of the erythrocyte plasma membrane has been subjected to a controlled proteolytic treatment with trypsin. The treatment has been previously shown to shift the enzyme from low to high Ca2+ affinity in the absence of calmodulin. The treatment leads to the fragmentation of the ATPase molecule into a number of products and to the accumulation of major limit polypeptides having Mr of 14,000, 28,000, 33,500, 48,000, and 76,000. The 33,500 Mr fragment reacts with 3(trifluoromethyl)-3 (m-[125I]iodophenyl)-diazirine, suggesting that it contains intramembrane regions of the enzyme. A number of minor fragmentation products were also formed, among them a polypeptide of Mr = 90,000 which is rapidly degraded further and a limit polypeptide of Mr about 25,000. [125I]Iodoazidocalmodulin cross-linked only to the original ATPase and to the fragments with Mr = 90,000 and Mr about 25,000. The Mr = 90,000 fragment can be isolated on calmodulin-Sepharose and on phenothiazine affinity columns. It retains the functional properties of the intact pump; it has a calmodulin-responsive ATPase activity and it actively accumulates Ca2+ upon incorporation into liposomes. Further proteolysis of the Mr = 90,000 fragment produces a fragment of Mr = 81,000-76,000 which forms an acylphosphate intermediate, which does not bind to calmodulin-Sepharose, and which seems to be responsible for the calmodulin-insensitive activity which appears as it is produced. A model is presented which postulates a major and a minor degradation pattern and rationalizes the pattern of proteolysis and of the [125I]iodoazidocalmodulin binding observed.
红细胞质膜纯化的Ca2+泵ATP酶已用胰蛋白酶进行了可控的蛋白水解处理。先前已证明,在没有钙调蛋白的情况下,该处理可使酶的Ca2+亲和力从低变高。该处理导致ATP酶分子断裂成许多产物,并积累了分子量分别为14,000、28,000、33,500、48,000和76,000的主要极限多肽。分子量为33,500的片段与3-(三氟甲基)-3-(间-[125I]碘苯基)-重氮甲烷反应,表明它含有该酶的膜内区域。还形成了一些次要的断裂产物,其中包括一个分子量为90,000的多肽,该多肽会迅速进一步降解,以及一个分子量约为25,000的极限多肽。[125I]碘叠氮钙调蛋白仅与原始的ATP酶以及分子量为90,000和约25,000的片段交联。分子量为90,000的片段可在钙调蛋白-琼脂糖和吩噻嗪亲和柱上分离。它保留了完整泵的功能特性;它具有钙调蛋白响应性ATP酶活性,并且在掺入脂质体后能主动积累Ca2+。分子量为90,000的片段进一步进行蛋白水解会产生一个分子量为81,000 - 76,000的片段,该片段形成一种酰基磷酸中间体,它不与钙调蛋白-琼脂糖结合,并且似乎是其产生时出现的钙调蛋白不敏感活性的原因。本文提出了一个模型,该模型假设了一种主要和一种次要的降解模式,并对观察到的蛋白水解模式和[125I]碘叠氮钙调蛋白结合模式进行了合理化解释。